Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The price of Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) closed at $11.01 in the last session, down -0.90% from day before closing price of $11.11. In other words, the price has decreased by -$0.90 from its previous closing price. On the day, 1.77 million shares were traded.
Ratios:
We take a closer look at BCRX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.88 and its Current Ratio is at 2.93.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on April 29, 2025, initiated with a Overweight rating and assigned the stock a target price of $20.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 13 ’24 when Hutson Nancy J sold 7,000 shares for $7.54 per share. The transaction valued at 52,780 led to the insider holds 86,638 shares of the business.
Hutson Nancy J bought 7,000 shares of BCRX for $52,584 on Dec 13 ’24. On Jun 24 ’24, another insider, McKee Amy E, who serves as the Director of the company, sold 8,600 shares for $6.32 each. As a result, the insider received 54,352 and left with 27,831 shares of the company.
Stock Price History:
Over the past 52 weeks, BCRX has reached a high of $11.31, while it has fallen to a 52-week low of $5.92. The 50-Day Moving Average of the stock is 20.82%, while the 200-Day Moving Average is calculated to be 34.80%.
Shares Statistics:
A total of 209.21M shares are outstanding, with a floating share count of 200.47M. Insiders hold about 4.19% of the company’s shares, while institutions hold 84.36% stake in the company.
